Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Yang <i>et al</i>.

Akiyama, Shintaro; Hamdeh, Shadi; Micic, Dejan; Sakuraba, Atsushi

Response to: 'Correspondence on 'Prevalence and clinical outcomes of COVID-19 in patients with autoimmune diseases: a systematic review and meta-analysis'' by Yang et al.

Akiyama, Shintaro; Hamdeh, Shadi; Micic, Dejan; Sakuraba, Atsushi.

Afiliação

Akiyama S; Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.
Hamdeh S; Department of Internal Medicine, Division of Gastroenterology, Hepatology and Motility, University of Kansas, Kansas City, Kansas, USA.
Micic D; Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA.
Sakuraba A; Inflammatory Bowel Disease Center, The University of Chicago Medicine, Chicago, Illinois, USA asakurab@medicine.bsd.uchicago.edu.

Ann Rheum Dis ; 82(4): e80, 2023 04.

Article em En | MEDLINE | ID: mdl-33452000

Assuntos

Doenças Autoimunes; COVID-19; Humanos; Doenças Autoimunes/complicações; Doenças Autoimunes/epidemiologia; Prevalência

Palavras-chave

COVID-19; autoimmune diseases; epidemiology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Autoimunes / COVID-19 Tipo de estudo: Prevalence_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google